Non-Alcoholic Fatty Liver Disease (NAFLD) Clinical Trials
2 recruiting trials for Non-Alcoholic Fatty Liver Disease (NAFLD). Eligibility criteria explained in plain English.
TrialFinderData lists 2 Non-Alcoholic Fatty Liver Disease (NAFLD) clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Every phased trial in this set is Phase 2 (1 of the listed studies); the remaining records are observational or have no phase recorded on ClinicalTrials.gov.
Research is led by University Hospitals Cleveland Medical Center (1), Hospital General Universitario Gregorio Marañon (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Milk thistle (MT) (drug, 1 trial), followed by Placebo, Lifestyle Modification.
Track Non-Alcoholic Fatty Liver Disease (NAFLD) trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Milk Thistle Clinical Trial in Pediatric NAFLD
Pediatric Fatty Liver disease is a growing problem in the United States and is expected to be the leading cause of Liver Transplantation in Adults in 20 years. Following lifestyle...
Automated Passive Case-Finding for Advanced Liver Fibrosis in MASLD: The LiverSeek Programme
LiverSeek is a fully automated, passive case-finding programme for advanced liver fibrosis associated with metabolic dysfunction-associated steatotic liver disease (MASLD) in...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Non-Alcoholic Fatty Liver Disease (NAFLD), with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Non-Alcoholic Fatty Liver Disease (NAFLD), review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Non-Alcoholic Fatty Liver Disease (NAFLD), representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.